Imcas TEAM:

Dear Dr MOBQUEL, welcome! The webinar will start at 5:30 PM, Paris time

Dr Maria Claudia GUZMAN SERRANO:

Buen dia

Dr Maria Claudia GUZMAN SERRANO:

Ya se supone que estoy reguistrado, solo debo esperar aqui a que comienze

Dr Maria Esther CHIRINOS:

BUENOS DIAS , SUPONGO QUE SERA POR AQUI?

Dr Maria Esther CHIRINOS:

HABRA ALGUNA MANERA DE PONR LA PANTALLA COMPLETA, GRACIAS

Jeremy JEANDIE:

Hola, Hello everyone :)

Dr Benjamin ASCHER:

Please guy's try to ask your question in English

Dr Chantal ZEITOUN AZOGUI:

Shalom from Israel:)

Serhiy CHOVHAN:

Украина с вами! Ukrainian with you)

Dr Mutaz ALNASER:

Hello from Jordan everyone

Imcas TEAM:

Welcome! Bienvenidos! We will start at 5:30 PM, Paris time

Jeremy JEANDIE:

Webinar is starting in few minutes then, super!

Dr Agnieszka SURA:

Hello from Poland

Dr Jesus Sebastian RODRIGUEZ GUTIERREZ:

Hello from Mexico!

Dr Maria Claudia GUZMAN SERRANO:

Saludos desde colombia

Dr Vefa Asli ERDEMIR:

Hello From Turkey

Dr Atoussa ARBAB:

Hello from France

Dr Isha POUDEL KOIRALA:

Hi I am from Nepal, South Asia. The screen here writes ‘ The live stream is either down or has ended. ‘

Dr Maria BENVENUTI:

Hello from Uruguay

Dr Nasim GHOLAMI GHARAB:

Hello,from Tehran

:

Hello from Italy

Dr Ivana ANDREJEVIC:

Hello from Belgrade ????

Dr Maria Esther CHIRINOS:

HELLO FROM VENZUELA

Imcas TEAM:

Hello everyone, welcome to IMCAS Academy monthly webinar on COVID-19 and Clinical Dermatology: what does it change?

Dr Anabel MANZONE:

Hello!! From Argentina

Imcas TEAM:

A special thanks to JEADV for being the Scientific Partner of this webinar.

Dr Maria BENVENUTI:

Beautiful Belgrado i love the city and thr people

Dr Houda MIKOU:

Hello from morocco

Jeremy JEANDIE:

It started. If it doesn't work, refresh the page.

Dr Venetia G BLIAMPTI VALAKOSTA:

Hello from Greece!

Dr Gladys Alejandra PAGUAGA MARTINEZ:

Ready! Hello from Mexico!

Dr Angela MURDZEVA:

Hello from North Macedonia!

Dr Zohreh NILFOROUSHAN DARDASHTI:

Dr Nilforoushan

Dr Luna AKSOY:

Hello from Ankara

Dr Ivana ANDREJEVIC:

Thank you Dr.Benvenuti????????

Imcas TEAM:

We are glad you could join us for this webinar, we kindly ask you to make the questions in English. They will be answered by the experts.

Dr Ghada ABDELBAKY:

Hello from Saudi Arabia

Dr Krisinda Clare Cuyong DIM JAMORA:

Hello from the Philippines

Dr Sri Shilpa POOJARI:

Hello from india

Prof Patrizia D ALESSIO:

Pr d'Alessio hello from Paris

Dr Jacqueline HELO HELO:

Hello from Colombia

Dr Mutaz ALNASER:

I have a patient with subungal melanoma berslow 3, of 12 year history

Dr Gamalat AZMY:

Hello from Egypt

Dr Grazyna WOLNIK - TRZECIAK:

Hello from Poland

Dr Mostafa YEHIA:

Hello from Egypt

Dr Maria Carolina GONZALEZ ASPILLAGA:

Hello from Chile

Dr Lea JACOBY:

Hallo from Israel

Dr Mutaz ALNASER:

No palpable LN and negative pet, no sentinel available, and now presented within the lockdown

Dr Dina KANDIL:

Hello form Egypt

Prof Omar BOUDGHENE STAMBOULI:

Pr omar boudghene stambouli Tlemcen algerie

Joyce LEUNG:

From vitiligo seeking repigmentation private practice

Dr Vikram Natraj GOYAL:

Namaste????

Dr Batoul REFFAI:

Hello from Uae

Dr Marie Diane F CHAN:

Hello from Philippines!

Dr Grace MENDOZA LOPEZ:

Hello from Philippines

Imcas TEAM:

We received a question from Doctor Abdullah Alazemi , dermatologist from Kuwait: ‘’Dear colleagues, how about management of Steven Johnson syndrome on Patient with COVID-19 positive?’’

Dr Asmaa Elsayed Mohye ABUELSAAD:

Hello from Egypy

Dr Silvana VISHAJ:

Hello from Albania

Dr Dragan ANDRIC:

Hello from Croatia

Dr Mariaesther VASQUEZ:

Saas

Dr Ayesha Yacub MOOLLA:

Hello from South Africa

Dr Mutaz ALNASER:

I have a patient with subungal melanoma berslow 3, of 12 year histroy, No palpable LN and negative pet, no sentinel available, and now presented within the lockdown, what are your recommendations in such circumstances?

Dr Irmina Shae M RAYMUNDO RODRIGUEZ:

Hello from the Philippines

Dr Carolina FELIPE:

Hello from Vitória, Brazil

Dr Mustafa NOORULDEEN:

Hi

Dr Milette DIVINAGRACIA TIO:

Hi colleagues from the Philippines! ????

Dr Miguel Mateo CUERVO LOPEZ:

Hello from Medellín, Colombia! Thanks for this webinar

Dr Luna AKSOY:

Urticaria cases with confirmed coronavirus

Dr Zulay RIVERA PINEDA:

Buenas, desde Caracas, Venezuela.

Dr Nayelli ORTEGA:

From Mexico, greetings to you all colleagues!

Imcas TEAM:

Please, feel free to ask your questions to the experts at any time. They will be answered during the debate.

Dr Sigrid Monina MARQUEZ:

From the Philippines Greetings to you Colleagues!

Dr Nay Maung Maung SAN:

Hello From Myanmar

Imcas TEAM:

We received a question from Doctor Pilar Cristobal , dermatologist from Spain: ‘’ What risks for dermatologists can laser treatments (hair removal, vascular, rejuvenation) have on a possible asymptomatic patient? ’’

Dr Andrea Sophia CARVAJAL NEVADO:

Hello! From Caracas, Venezuela. Thank you.

Dr Amelia FRISCHANANTA:

Hi from Indonesia

Dr Luna AKSOY:

Screening for coronavirus before procedure?

Dr Francis A CABAN:

Any difference approaching MMIS vs Mm Less than 1 mm in thickness?

Dr Isha POUDEL KOIRALA:

What is your take on use od steroids(oral or topical) for dermatologic conditions in covid 19 positive patients?

Dr Amelia FRISCHANANTA:

I would like to ask, is skin to skin transmision possible in covid-19?

Dr Oon Siang KHOO:

Hello from Malaysia

Dr Eliana SAN JUAN:

Hellow from EEUU

Dr Nay Maung Maung SAN:

How about methotrexate and cyclosporin usage in covid 19 ?

Dr Luis BRINGAS:

AINE´s should be interrupted?

Dr Mostafa YEHIA:

Are there other theories from dermatological point of view of coronavirus transmission other than skin to skin?

Dr Mostafa YEHIA:

Is coronavirus proven to be transmitted through skin to skin?

Prof Patrizia D ALESSIO:

Pr Patrizia d'Alessio Covid-19 is also about thrombo-embolism treated with thrombolytics and anti-biotics : can those be considered as preventive options allowing to reduce immune-suppressive treatments ?

Dr Khaled Ahmed BAHAMDAN:

There is no more transmissions, the webinar is interrupted

Prof Patrizia D ALESSIO:

Transmission is perfect and the French colleague is brilliant

Jeremy JEANDIE:

It's working well here, please refresh the page

Imcas TEAM:

Dr BAHAMDAN, please try refreshing your website. Thanks.

Dr Khaled Ahmed BAHAMDAN:

Error code 220001

Dr Venetia G BLIAMPTI VALAKOSTA:

What about the apremilast therapy during this period?

Dr Florian Clemens HEYDECKER:

Error 232001

Dr Mustafa NOORULDEEN:

Interrupted

Dr Florian Clemens HEYDECKER:

Ok it works

Dr Mustafa NOORULDEEN:

Ok

Dr N AHMED:

How to deal with pemphigus vulgaris pts on high dose prednisolone?

Dr Hugues CARTIER:

Do we find active covid in the injured skin like psoriasis or atopic dermatitis crust. Can you confirm that there is no risk of cutaneous transmission skin / skin ( not skin- mucous)

Dr Mustafa NOORULDEEN:

Thank you Dr. Ahmed

Imcas TEAM:

Dr CUESTAD, please notice that this webinar will be available for free on IMCAS Academy in less than 48 hours. You will be notified by email.

Dr Abdullah ALAZEMI:

What is the recommendation for Management steven Johnson Syndrom or TENS with positive COVID 19 ?

Dr Corinne GRANGER:

Dr GrangerVery good webinar

Dr Mutaz ALNASER:

I have a patient with subungal melanoma berslow 3, of 12 year histroy, No palpable LN and negative pet, no sentinel available, and now presented within the lockdown, what are your recommendations in such circumstances

Dr Mutaz ALNASER:

Rightbthumb tip

Dr Eliana SAN JUAN:

Dear Colleagues, how can treat the eritema pernio like lessions?lesion

Dr Soheir ELTOUKHY:

Thank you Dr Sadek .excellent webinar

Dr Mutaz ALNASER:

New diagnosed

Dr Mutaz ALNASER:

Thank you

Dr Isha POUDEL KOIRALA:

Efficiently organised webinar, informative speakers. Thanks to the organizers and the speakers!

Dr Mustafa NOORULDEEN:

Great work Thank you all

Dr Abdullah ALAZEMI:

Thank you a lot

Dr Lajos KEMENY:

Lajos Kemeny comment on DIC: Coagulopathy Associated with COVID-19 (NEJM)

Dr Matthieu BEUSTES STEFANELLI:

Are U aware of any post Hyaluronic Acid injection granuloma in Covid patients? do U think that SARS-Cov-2 as others virus could increase this complication?

Dr Soheir ELTOUKHY:

Thanks to organizers and speakers.

Dr Mustafa NOORULDEEN:

Before several days they were taking about ivermectin in treatment of Covid 19 What are your opinion

Dr Greys GONZALEZ:

Excelent webinar, thank hoy all

Dr Alejandra PEYRE:

Thank you very much to all, excelent webinar. From Uruguay.

Dr Matthieu BEUSTES STEFANELLI:

Apparently ICU are not seeing severe patients that are under long term systemic steroids for conditions such as Lupus or Rhumatoid arthritis...do U think that steroids could protect against severe COVID?

Dr Eliana SAN JUAN:

Dears colleagues How we can treat the Eritema Pernio likes associatted with pain and paresthesias

Dr Mustafa NOORULDEEN:

Do atopic patients more susceptable for infection with Covid?

Dr Eliana SAN JUAN:

Eliana San Jun Dermatologa Spain and Venezuela

Dr Fadua BESIL EGUIA:

Thank you!! Amazin webinar!! Greretings from Mexico City!! What do younthink about cronic urtcaria patients on omalizumab? Should I postpone treatment? Tnanks

Dr Oon Siang KHOO:

Thank you very much for this informative webinar.

Dominique DU CREST:

For information, on top of my conclusion: PsoProtect is an international registry for clinicians to report outcomes of COVID-19 in individuals with psoriasis. https://psoprotect.org

Dr Maria Esther CHIRINOS:

Thanks at lot from Venezuela,excelent webinar

Imcas TEAM:

This webinar will be available for free on IMCAS Academy in less than 48 hours. You will be notified by email.

Imcas TEAM:

Again a special thanks to JEADV for being the scientific partner of this webinar and to our speakers for their time and expertise shared making this webinar possible.

Dr Walaa SULTAN:

Thank you all very much. From Egypt

Dr Soledad MACHADO:

Thank you for your time. Great webinar!! Best from Uruguay

Dr Venetia G BLIAMPTI VALAKOSTA:

Thank you for excellent and enlightening presentations !

Dr Hugues CARTIER:

Subsidiary question, which of the speakers are covid + ? Otherwise , take care and be safe. Thanks for thou webinar.

Dr Poramet KUNAKORNWONG:

Thank you so much. From Thailand

Dr Agnieszka Anna SNARSKA DRYGALSKA:

Thank you very good webinar

Androniki BANASA:

Thank you very much